Jeewat Bijlani - 20 Dec 2023 Form 4 Insider Report for QUAKER CHEMICAL CORP (KWR)

Role
EVP, Chief Strategy Officer
Signature
Victoria K. Gehris, Attorney-in-Fact for Jeewat Bijlani
Issuer symbol
KWR
Transactions as of
20 Dec 2023
Net transactions value
-$449,704
Form type
4
Filing time
22 Dec 2023, 16:15:43 UTC
Previous filing
18 Dec 2023
Next filing
19 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KWR Common Stock Options Exercise $375,061 +2,421 +47% $154.92 7,520 20 Dec 2023 Direct F1
transaction KWR Common Stock Sale $532,620 -2,421 -32% $220.00 5,099 20 Dec 2023 Direct F1
transaction KWR Common Stock Options Exercise $291,405 +1,881 +37% $154.92 6,980 20 Dec 2023 Direct F1
transaction KWR Common Stock Sale $413,820 -1,881 -27% $220.00 5,099 20 Dec 2023 Direct F1
transaction KWR Common Stock Options Exercise $278,199 +2,036 +40% $136.64 7,135 20 Dec 2023 Direct F1
transaction KWR Common Stock Sale $42,240 -192 -2.7% $220.00 6,943 20 Dec 2023 Direct F1
transaction KWR Common Stock Sale $405,688 -1,844 -27% $220.00 5,099 20 Dec 2023 Direct F1, F2
holding KWR Common Stock 59 20 Dec 2023 By 401(k)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -2,421 -100% $0.000000* 0 20 Dec 2023 Common Stock 2,421 $154.92 Direct F1, F3
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -1,881 -74% $0.000000 645 20 Dec 2023 Common Stock 1,881 $154.92 Direct F1, F4
transaction KWR Employee Stock Option (right to buy) Options Exercise $0 -2,036 -74% $0.000000 731 20 Dec 2023 Common Stock 2,036 $136.64 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The exercise of the options and the sale of shares reported for this transaction was effected pursuant to a Rule 10b5-1 Plan entered into by reporting person on August 31, 2023.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $220.00 to $220.13, inclusive. The reporting person undertakes to provide to Quaker Chemical Corporation, d/b/a "Quaker Houghton", any security holder of Quaker Houghton, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The options for this grant vested in three annual installments: 807 shares on August 15, 2019; 807 shares on February 26, 2020; and 807 shares on February 26, 2021.
F4 The options for this grant vested in three annual installments: 842 shares on February 25, 2020; 842 shares on February 25, 2021; and 842 shares on February 25, 2022.
F5 The options for this grant vested in three annual installments: 923 shares on March 30, 2021; 922 shares on March 30, 2022; and 922 shares on March 30, 2023.